Dallas, TX & Atlanta, GA – [Insert Current Date] – In a transformative move set to redefine the landscape of patient care in orthotics, prosthetics, and complex rehabilitation technology across North America, Hanger Inc., a leading provider of orthotic and prosthetic (O&P) services, has announced its acquisition of Numotion, a premier provider of complex rehabilitation technology (CRT) and mobility solutions. This strategic combination will create a formidable new entity, Hanger Numotion, establishing a scaled platform with unparalleled capabilities to serve over 1.5 million patients annually. The transaction, structured as a cash acquisition of Numotion by Hanger, will ultimately place the combined company under the control of Patient Square Capital, a dedicated healthcare investment firm, signaling a long-term vision for leadership and innovation in the mobility sector.
This merger represents a significant consolidation within the specialized healthcare services market, bringing together two industry giants with complementary strengths. Hanger, renowned for its extensive network of O&P clinics and patient care solutions, will integrate with Numotion, a portfolio company of AEA Investors, recognized for its expertise in providing custom complex rehabilitation technology, including power wheelchairs, adaptive seating, and related mobility products and services across the U.S. and Canada. The newly formed Hanger Numotion aims to create a seamless continuum of care, addressing a broader spectrum of patient needs from post-amputation prosthetic fitting to advanced mobility solutions for individuals with complex medical conditions.
Main Facts: A New Era in Mobility Solutions
The genesis of Hanger Numotion marks a pivotal moment for individuals requiring specialized mobility and independence solutions. This newly formed entity will stand as a beacon of integrated care, merging Hanger’s deep heritage in orthotics and prosthetics with Numotion’s cutting-edge capabilities in complex rehabilitation technology.
Strategic Alignment and Expanded Reach: The core of this acquisition lies in the strategic alignment of two distinct yet highly complementary service offerings. Hanger, with its network of 925 U.S.-based O&P clinics, provides custom-fitted devices such as artificial limbs, braces, and cranial helmets, playing a crucial role in rehabilitation and functional restoration. Numotion, operating from over 200 locations across North America, specializes in highly customized mobility solutions, including complex power wheelchairs, manual wheelchairs, adaptive seating, and other assistive technologies designed to enhance the independence of individuals with significant physical disabilities. By bringing these services under one umbrella, Hanger Numotion will create an integrated ecosystem that can address a patient’s journey comprehensively, from initial diagnosis and prosthetic fitting to long-term complex mobility needs.
Unprecedented Scale and Patient Impact: The combined organization is projected to serve more than 1.5 million patients annually across the United States and Canada. This represents an extraordinary scale, enabling Hanger Numotion to exert significant influence on patient access to care, product innovation, and clinician development. The expanded geographic footprint and diversified service portfolio are expected to facilitate greater efficiency in operations, enhanced purchasing power, and a more robust platform for technological advancements in both O&P and CRT. For patients, this translates into potentially easier access to a wider range of high-quality services, improved coordination of care, and solutions tailored to their evolving needs throughout their lives.
Leadership Transition and Vision: A key element of this merger involves a strategic leadership transition. Upon the completion of the transaction, Mike Swinford, the highly successful CEO of Numotion since 2014, will assume the role of CEO for the combined Hanger Numotion. Swinford brings a wealth of experience, having scaled Numotion into a mobility leader through sustained growth and diversification, following a distinguished two-decade career at GE, including as President and CEO of GE Healthcare Services. Pete Stoy, the current CEO of Hanger Inc., who has overseen a significant transformation of the company since joining in 2020, will transition from his role. This leadership structure is designed to leverage Swinford’s proven track record in complex mobility solutions and his vision for integrated patient care.
Financial Control and Strategic Investment: The transaction is structured as an acquisition of Numotion for cash by Hanger. Following the close, the combined entity, Hanger Numotion, will be controlled by Patient Square Capital. Patient Square Capital is known for its deep expertise and long-term investment horizon in the healthcare sector, suggesting a strategic commitment to fostering innovation, expanding market reach, and enhancing the quality of care provided by the new company. This backing from a specialized healthcare investor underscores the significant potential and strategic importance of Hanger Numotion within the broader healthcare landscape.
Anticipated Timeline: The completion of this landmark acquisition is anticipated in the fourth quarter of 2026, subject to customary closing conditions, including regulatory approvals. This timeline allows for meticulous planning and execution of the integration process, ensuring a smooth transition for patients, employees, and stakeholders. Both Hanger and Numotion will continue to operate under their existing brands and maintain their respective clinical operations post-acquisition, at least initially, to ensure continuity of service and minimize disruption.
Chronology: A Path to Integration
The journey leading to the formation of Hanger Numotion is rooted in the individual evolutions of two industry leaders and a shared strategic vision for comprehensive patient care.
Hanger’s Enduring Legacy and Recent Transformation: Hanger Inc. boasts a rich history, tracing its origins back to the mid-19th century. Founded by James Edward Hanger, the first amputee of the Civil War, the company pioneered prosthetic innovation. Over generations, Hanger grew to become the largest provider of O&P services in the U.S., establishing a vast network of clinics and a reputation for clinical excellence. More recently, Hanger has undergone a significant strategic transformation, particularly under the leadership of Pete Stoy, who joined as CEO in 2020. Stoy focused on building a stronger, more integrated national platform, investing heavily in people, technology, and capabilities. His tenure positioned Hanger for sustained growth and enhanced its ability to provide high-quality O&P care, setting the stage for this expansive merger.
Numotion’s Rise as a Mobility Leader: Numotion, while a more recent entity in its current form, has rapidly ascended to become a leading provider of complex rehabilitation technology and mobility products and services across the U.S. and Canada. Its growth has been particularly pronounced since 2014, under the strategic guidance of CEO Mike Swinford. Swinford, with his extensive background in scaling businesses and his previous experience at GE Healthcare Services, successfully diversified Numotion’s offerings and expanded its geographic footprint. As a portfolio company of AEA Investors, Numotion benefited from significant investment and strategic partnership, enabling it to innovate in customized mobility solutions and strengthen its market position.
The Strategic Rationale for Combination: The idea of combining Hanger and Numotion emerged from a recognition of the inherent synergies between O&P and CRT services. While distinct, both address fundamental aspects of patient mobility and independence. Industry trends have increasingly pointed towards the need for more integrated care pathways, where patients can access a full spectrum of rehabilitation and assistive technologies from a single, trusted provider. Strategic discussions between the leadership teams of Hanger and Numotion, facilitated by Patient Square Capital’s long-term investment perspective, crystallized the vision for a unified platform. This vision was driven by the shared belief that a combined entity could offer a more holistic and efficient patient experience, leveraging economies of scale and expertise.
The Announcement and Anticipated Close: The formal announcement of the acquisition marks the culmination of these strategic deliberations and due diligence. While the specific date of the public announcement is inferred, its significance lies in signaling a major shift in the specialized healthcare market. The anticipated closing in the fourth quarter of 2026 allows ample time for regulatory reviews, which are standard for transactions of this magnitude, and for meticulous planning of the operational and cultural integration process. This extended timeline underscores the complexity and strategic importance of combining two large, patient-focused organizations, ensuring that the transition is smooth and ultimately beneficial for all stakeholders, most importantly, the patients they serve.
Supporting Data: Market Dynamics and Synergies
The formation of Hanger Numotion is not merely an aggregation of two companies but a strategic response to evolving market dynamics and a proactive step towards realizing significant synergies that will benefit patients, clinicians, and the broader healthcare system.
Market Analysis: Growth Drivers in O&P, CRT, and Mobility:
- Orthotics and Prosthetics (O&P): The O&P market is characterized by steady growth, driven by several factors. An aging global population, increased prevalence of chronic diseases such as diabetes (leading to amputations), advancements in prosthetic and orthotic technologies (e.g., microprocessors, advanced materials, 3D printing), and improved access to rehabilitation services all contribute to expanding demand. O&P devices are critical for restoring mobility, function, and quality of life for individuals with limb loss or musculoskeletal impairments.
- Complex Rehabilitation Technology (CRT): The CRT market is also experiencing robust growth, fueled by a rising number of individuals with complex disabilities requiring highly personalized mobility solutions. Conditions such as spinal cord injuries, cerebral palsy, multiple sclerosis, muscular dystrophy, and amyotrophic lateral sclerosis necessitate specialized power wheelchairs, custom seating, and adaptive equipment. Technological innovations, including smart features, advanced controls, and ergonomic designs, are continually improving the efficacy and user experience of CRT products.
- Mobility Services and Integrated Care: Beyond specific devices, there’s a growing demand for comprehensive mobility services that encompass assessment, fitting, training, maintenance, and long-term support. The healthcare system is increasingly moving towards integrated care models that prioritize holistic patient outcomes, reduce fragmentation, and enhance care coordination.
Synergies: A Holistic Continuum of Care: The combination of Hanger’s O&P expertise with Numotion’s CRT and mobility solutions creates a powerful synergy.
- Comprehensive Patient Journey: Patients often require both O&P and CRT services at different stages of their lives or for co-occurring conditions. For example, an amputee may need a prosthetic limb (O&P) and also a specialized wheelchair (CRT) for certain activities or for periods of non-weight bearing. An individual with a progressive neurological condition might first require orthotic support and later advanced power mobility. Hanger Numotion can now offer a seamless "continuum of care," preventing patients from having to navigate multiple, disconnected providers.
- Enhanced Access and Referral Networks: With 925 Hanger clinics and over 200 Numotion locations, the combined entity boasts an unparalleled geographic reach across North America. This expanded network will improve patient access, particularly in underserved areas, and create robust internal referral pathways, simplifying the patient experience and ensuring timely access to appropriate care.
- Cross-Pollination of Expertise: The integration will foster a unique environment for the exchange of clinical best practices, technical knowledge, and patient management strategies between O&P clinicians and CRT specialists. This interdisciplinary collaboration is expected to lead to more innovative solutions and better patient outcomes.
Financial Implications and Investment Strategy: While specific financial terms were not disclosed beyond a cash acquisition, the strategic implications are substantial.
- Increased Revenue Scale and Operational Efficiencies: The combined entity will immediately achieve significant revenue scale, leading to potential operational efficiencies through shared administrative functions, optimized supply chain management, and consolidated IT infrastructure. These economies of scale can free up resources for further investment in patient care.
- Enhanced Market Position and Negotiating Power: As a dominant player in both O&P and CRT, Hanger Numotion will have a stronger market position, potentially leading to improved negotiating power with manufacturers, suppliers, and insurance payors. This could translate into better pricing for products and services, ultimately benefiting patients and the company’s financial health.
- Investment in Innovation and Technology: The larger financial base and strategic backing from Patient Square Capital will enable significant investment in research and development, cutting-edge technologies (e.g., AI-driven diagnostics, advanced robotics, personalized manufacturing), and state-of-the-art clinical tools. This commitment to innovation is crucial for staying ahead in rapidly evolving fields.
- Patient Square Capital’s Role: As a healthcare-focused investment firm, Patient Square Capital’s control signifies a long-term strategic commitment to building a market leader dedicated to improving patient outcomes. Their expertise in healthcare investments suggests a focus on sustainable growth, clinical excellence, and leveraging data-driven insights to optimize care delivery.
Patient Impact: A New Standard of Care: The ultimate beneficiaries of this merger are the patients.
- Streamlined Access and Coordination: Patients will experience a more streamlined process for accessing both O&P and CRT services, reducing administrative burdens and ensuring better coordination between different care providers.
- Broader Range of Solutions: The combined product and service portfolio will offer patients a wider array of advanced and customized solutions, ensuring they receive the most appropriate technology for their specific needs.
- Enhanced Patient Experience: The focus on integrated care and investment in clinician training and technology is expected to elevate the overall patient experience, leading to greater satisfaction and improved long-term outcomes.
Official Responses: Voices of Vision and Confidence
The announcement of the Hanger Numotion merger was met with enthusiastic endorsements from the key figures driving this strategic combination, emphasizing a shared commitment to patient well-being and a vision for a more integrated future.
Mike Swinford, Incoming CEO of Hanger Numotion:
Mike Swinford, currently the CEO of Numotion and slated to lead the combined entity, articulated a compelling vision for the new company. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives," Swinford stated, highlighting the core philosophical alignment underpinning the merger. He emphasized the synergistic potential, adding, "By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys." Swinford’s remarks underscore a patient-centric approach, focusing on expanding the reach and depth of services to positively impact a greater number of individuals.
In his statement, Swinford also extended gratitude to the partners who contributed to Numotion’s success. "I’d like to personally thank Pete [Stoy] for his outstanding leadership, AEA [Investors] for its strong partnership and commitment as Numotion’s primary investor, and LLR for its longstanding investment in and support of the company," he said. This acknowledgment reflects a collaborative spirit and recognizes the collective efforts that have led to this pivotal moment. Looking ahead, Swinford expressed his excitement for the integration process: "I look forward to working with teams across Hanger, Numotion, and Patient Square as we bring our organizations together and advance our shared commitment to helping people live with greater mobility and independence." His leadership will be critical in navigating the complexities of integrating two large organizations while maintaining a steadfast focus on their shared mission.
Pete Stoy, Current CEO of Hanger Inc.:
Pete Stoy, who has spearheaded Hanger’s transformation since 2020, conveyed immense pride in his team’s accomplishments and expressed strong confidence in the future leadership. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020," Stoy remarked. He elaborated on the significant strides made during his tenure, stating, "Together, we have built a stronger, more integrated national platform, invested meaningfully in our people, technology, and capabilities, and positioned Hanger for sustained growth." This reflects a legacy of strategic investment and operational enhancement that has prepared Hanger for this expansive new chapter.
Stoy also offered a powerful endorsement of his successor, Mike Swinford. "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction," he affirmed. Stoy recognized Swinford’s leadership qualities, adding, "He is an accomplished leader who shares our commitment to patients and our people, and I believe he is well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead." This seamless transition of leadership, marked by mutual respect and shared objectives, is crucial for fostering stability and continuity during the integration phase.
Patient Square Capital’s Perspective:
While no direct quote from Patient Square Capital was provided in the original summary, their role as the controlling entity of the combined company speaks volumes about their strategic rationale. As a healthcare-focused investment firm, Patient Square Capital’s decision to back Hanger Numotion underscores a belief in the long-term growth potential of the integrated O&P and CRT market. Their investment is likely driven by the opportunity to:
- Create a Market Leader: By combining Hanger and Numotion, Patient Square Capital is consolidating two leading players to form a dominant force in specialized mobility solutions.
- Leverage Sector Expertise: Their deep understanding of the healthcare industry allows them to identify and capitalize on trends toward integrated care, patient-centric models, and technological innovation.
- Drive Value Creation: Through strategic guidance, operational optimization, and capital allocation, Patient Square Capital aims to enhance the value of Hanger Numotion, ultimately improving patient care while generating sustainable returns. Their commitment signals a long-term vision focused on building a robust, resilient, and highly impactful healthcare enterprise.
Implications: Reshaping the Future of Mobility
The formation of Hanger Numotion carries profound implications that extend beyond the two merging entities, potentially reshaping the competitive landscape, service delivery models, and future trajectory of specialized mobility solutions across North America.
Industry Transformation and Consolidation:
This landmark acquisition is poised to be a catalyst for significant industry transformation.
- New Industry Benchmark: Hanger Numotion, with its unprecedented scale and integrated service model, will set a new benchmark for comprehensive patient care in the O&P, CRT, and broader mobility sectors. This could compel other providers to re-evaluate their strategies, potentially leading to further consolidation as smaller players seek to compete or larger entities look to expand their offerings.
- Shift Towards Integrated Care: The merger strongly reinforces the growing trend towards integrated healthcare solutions. Payors, healthcare systems, and patients are increasingly demanding coordinated care that addresses multiple needs through a single, accountable provider. Hanger Numotion is uniquely positioned to deliver this, demonstrating the viability and benefits of a holistic approach to mobility.
- Impact on Smaller Providers: While the merger creates a powerful new entity, it also raises questions for smaller, independent O&P clinics and CRT providers. They may face increased competitive pressure or explore opportunities for partnerships or niche specialization to thrive alongside this new giant.
Strategic Growth and Future Outlook:
The long-term vision for Hanger Numotion, particularly under the control of Patient Square Capital, appears focused on sustained growth and innovation.
- Expanded Access and Market Penetration: With a combined footprint across the U.S. and Canada, Hanger Numotion can expand access to care in both urban and rural areas. This scale also provides a robust platform for further market penetration, potentially through strategic acquisitions of smaller, specialized providers or organic growth into new geographic regions.
- Innovation Ecosystem: The combined resources and intellectual capital of Hanger and Numotion will foster a powerful innovation ecosystem. This could lead to accelerated development and adoption of new technologies in prosthetics (e.g., advanced bionics), orthotics (e.g., smart orthoses), and CRT (e.g., AI-powered wheelchairs, remote monitoring solutions). Investment in R&D and pilot programs for new care models will likely be a significant focus.
- Talent Development and Retention: A key stated goal is to "invest in clinicians." This implies enhanced training programs, career development opportunities, and competitive compensation to attract and retain the best O&P practitioners, CRT specialists, and rehabilitation therapists. A strong talent base is crucial for delivering high-quality, patient-centric care.
- Data-Driven Care: The scale of patient data generated by serving over 1.5 million individuals annually presents an immense opportunity. Hanger Numotion can leverage this data to inform clinical best practices, personalize patient care, optimize outcomes, and demonstrate the value of their services to payors.
Regulatory Scrutiny and Integration Challenges:
While the strategic rationale is clear, the path to integration will not be without challenges.
- Regulatory Review: Given the significant size and market share of the combined entity in specialized healthcare segments, the transaction will likely undergo rigorous antitrust review by regulatory bodies in both the U.S. and Canada. This process, anticipated within the Q4 2026 closing timeline, will ensure fair competition and prevent monopolistic practices.
- Integration Complexities: Merging two large organizations with distinct corporate cultures, operational systems, and clinical practices is inherently complex. Key challenges will include:
- Cultural Alignment: Harmonizing the cultures of Hanger and Numotion while maintaining the unique strengths of each.
- System Integration: Consolidating IT systems, billing platforms, and supply chains without disrupting patient care or administrative efficiency.
- Brand Management: Deciding how to manage existing brands (Hanger and Numotion will initially continue under their existing brands) to leverage brand equity while communicating the benefits of the combined entity.
- Talent Retention: Ensuring that key clinical and administrative staff feel valued and supported throughout the transition to prevent talent drain.
Overall Outlook:
Despite the inherent challenges, the long-term outlook for Hanger Numotion appears exceptionally promising. By combining their strengths, these two industry leaders are poised to create a more resilient, innovative, and patient-centric enterprise. The merger represents a bold step towards a future where individuals with mobility challenges receive comprehensive, integrated, and technologically advanced care, ultimately enhancing their independence and improving their quality of life. As the healthcare landscape continues to evolve, Hanger Numotion stands ready to lead the charge in defining the next generation of specialized mobility solutions.
